SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia

Summary

Phase I/II trial to study the effectiveness of SGN-00101 in preventing anal cancer in HIV-positive patients who have high-grade anal neoplasia. Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. SGN-00101 may be effective in preventing anal cancer.

Timeline

Start

2002-12

Primary completion

2005-07

Completion

—

Drugs

Indications